Blue Apron Q2 revenue $124.2 mln vs. $124.0 mln a year ago; FactSet consensus $124.9 mln
Blue Apron Q2 per-share loss 68 cents vs. loss 98 cents a year ago
First Solar upgraded to overweight from neutral at J.P. Morgan
Elevation Oncology downgraded to neutral from overweight at J.P. Morgan
Carvana downgraded to underweight from neutral at J.P. Morgan
Ball Corp. downgraded to neutral from overweight at J.P. Morgan
Lifetime Brands stock price target cut to $11.00 from $17.50 at D.A. Davidson
Redfin stock price target cut to $10.50 from $13.00 at Susquehanna
Canopy Growth stock price target cut to C$2 from C$5 at Benchmark
Five Below stock price target cut to $190 from $210 at KeyBanc Capital
Constellation Energy stock price target raised to $87 from $70 at KeyBanc Capital
BioNTech stock sinks more than 8% after profit, revenue fall below expectations
BioNTech affirms 2022 COVID-19 vaccine revenue EUR13 bln-EUR17 bln
Virtual Stock Exchange